Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 103Terminated 27Withdrawn 10Recruiting 5Unknown 4Active not recruiting 3Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 14Other hematologic neoplasm 4Plasma cell 3Dermatologic 1

Conditions

Melanoma 70Skin Neoplasms 17Carcinoma, Basal Cell 16Lymphoma, T-Cell, Cutaneous 12Neoplasms 9Keratosis, Actinic 8Carcinoma, Non-Small-Cell Lung 7Lung Neoplasms 6Carcinoma, Squamous Cell 6Carcinoma, Merkel Cell 6Mycosis Fungoides 5Colorectal Neoplasms 5Carcinoma, Renal Cell 5Breast Neoplasms 5Uveal Melanoma 4Sezary Syndrome 4Neoplasm Metastasis 4Uterine Cervical Neoplasms 3Sarcoma 3Endometrial Neoplasms 3Urogenital Neoplasms 2Triple Negative Breast Neoplasms 2Thyroid Neoplasms 2Testicular Neoplasms 2Stomach Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Recurrence 2Prostatic Neoplasms 2Pancreatic Neoplasms 2Ovarian Neoplasms 2

Interventions

Sirolimus 1Prednisone 1Everolimus 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Waldenstrom Macroglobulinemia × Dermatologic × Clear all
NCT07426484 2026-02-23

Cosibelimab for CSCC in Patients With Kidney Transplant or Hematologic Malignancy

Dana-Farber Cancer Institute

Phase 4 Not yet recruiting
80 enrolled
DermatologicLymphoidOther hematologic neoplasmPlasma cell

Lymphoma, Waldenstrom Macroglobulinemia, Skin Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡